Drug Profile
G 49
Latest Information Update: 28 Oct 2020
Price :
$50
*
At a glance
- Originator MedImmune
- Class Antihyperglycaemics
- Mechanism of Action Glucagon like peptide 1 receptor agonists; Glucagon receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Liver disorders
Most Recent Events
- 28 Oct 2020 No recent reports of development identified for preclinical development in Liver-disorders(Prevention) in USA (SC, Injection)
- 01 Oct 2018 Pharmacodynamics data from preclinical trial in Liver disorders presented at 54th Annual Meeting of the European Association for the Study of Diabetes (EASD-2018)
- 29 Sep 2016 Pharmacodynamics and pharmacokintics data from a preclinical trial in Liver disorders presented at the 52nd Annual Meeting of the European Association for the Study of Diabetes (EASD-2016)